Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Nanayakkara

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
European Journal of Heart Failure|August 23, 2023
No longer from pillar to post: The first effective step in treating heart failure with preserved ejection fractionShane Nanayakkara, David M Kaye
Interventional Cardiology Clinics|May 31, 2020
Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney InjuryShane Nanayakkara, David M Kaye
Frontiers in Cardiovascular Medicine|October 18, 2019
Interatrial Shunt Device for Heart Failure With Preserved Ejection FractionDavid M Kaye, Shane Nanayakkara
Heart Failure Reviews|April 19, 2022
Device therapy with interatrial shunt devices for heart failure with preserved ejection fractionShane Nanayakkara, David M Kaye
Clinical Therapeutics|September 20, 2015
Management of heart failure with preserved ejection fraction: a reviewShane Nanayakkara, David M Kaye
Frontiers in Cardiovascular Medicine|August 22, 2022
Editorial: Translating artificial intelligence into clinical use within cardiologyPaul Leeson, Shane Nanayakkara, Pablo Lamata
Journal of the American Heart Association|June 25, 2019
Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial SubstudyAnna L Beale, Shane Nanayakkara, David M Kaye
Australian Prescriber|March 7, 2020
Management of heart failure with preserved ejection fractionEmma Gard, Shane Nanayakkara, David Kaye, et al.
Pharmacology & Therapeutics|May 20, 2015
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairmentNiwanthi W Rajapakse, Shane Nanayakkara, David M Kaye
Clinical Medicine Insights. Cardiology|January 19, 2018
Hospitalisation in Patients With Heart Failure With Preserved Ejection FractionShane Nanayakkara, Hitesh C Patel, David M Kaye
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|August 23, 2023
No longer from pillar to post: The first effective step in treating heart failure with preserved ejection fractionShane Nanayakkara, David M Kaye
Interventional Cardiology Clinics|May 31, 2020
Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney InjuryShane Nanayakkara, David M Kaye
Frontiers in Cardiovascular Medicine|October 18, 2019
Interatrial Shunt Device for Heart Failure With Preserved Ejection FractionDavid M Kaye, Shane Nanayakkara
Heart Failure Reviews|April 19, 2022
Device therapy with interatrial shunt devices for heart failure with preserved ejection fractionShane Nanayakkara, David M Kaye
Clinical Therapeutics|September 20, 2015
Management of heart failure with preserved ejection fraction: a reviewShane Nanayakkara, David M Kaye
Frontiers in Cardiovascular Medicine|August 22, 2022
Editorial: Translating artificial intelligence into clinical use within cardiologyPaul Leeson, Shane Nanayakkara, Pablo Lamata
Journal of the American Heart Association|June 25, 2019
Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial SubstudyAnna L Beale, Shane Nanayakkara, David M Kaye
Australian Prescriber|March 7, 2020
Management of heart failure with preserved ejection fractionEmma Gard, Shane Nanayakkara, David Kaye, et al.
Pharmacology & Therapeutics|May 20, 2015
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairmentNiwanthi W Rajapakse, Shane Nanayakkara, David M Kaye
Clinical Medicine Insights. Cardiology|January 19, 2018
Hospitalisation in Patients With Heart Failure With Preserved Ejection FractionShane Nanayakkara, Hitesh C Patel, David M Kaye
Pageof 12